Colossal Biosciences has re-engineered the egg. The company’s shell-less artificial egg system is shown alongside a developing embryo and one of the chicks successfully hatched from the 3D-printed incubation device. Colossal says the platform could support future conservation efforts and the de-extinction of giant birds such as the South Island Giant Moa. [Image: Colossal Biosciences]
Left: LinedanceAI co-founder Mohamed Elwazer; Center illustration: leonello/iStock; Right: Lantern Pharma CEO Panna Sharma
Dallas-Fort Worth is well known for its tech expertise. Now it being recognized as the place where technology meets life science—a convergence that’s driving rapid growth in the biotech ecosystem. Leaders in the industry attribute this success to the unique convergence of the region’s exceptional tech talent pool and cutting-edge developments in life science....
Colossal leadership team, L to R: Peter Phillips, chief business officer; Andrew Busey, chief product officer; Sarah Grant, chief of staff; Ben Lamm, co-founder/CEO; George Church, PhD, co-founder; Eriona Hysolli, head of biological sciences; Kent Wakeford, COO; and Brian Beard, chief legal officer. [Photo credit: John Davidson Photography]